No abstract

Bee venom (1-10 µg/ml) and melittin (0.5-2.5 µg/ml) inhibited cancer cell growth through induction of apoptotic cell death in LNCaP, DU145, and PC-3 human prostate cancer cells. These effects were mediated by the suppression of constitutively activated NF-κB. Bee venom and melittin decreased anti-apoptotic proteins but induced pro-apoptotic proteins. However, pan caspase inhibitor abolished bee venom and melittin-induced apoptotic cell death and NF-κB inactivation. Bee venom (3-6 mg/kg) administration to nude mice implanted with PC-3 cells resulted in inhibition of tumor growth and activity of NF-κB accompanied with apoptotic cell death. Therefore, these results indicated that bee venom and melittin could inhibit prostate cancer in in vitro and in vivo, and these effects may be related to NF-κB/caspase signal mediated induction of apoptotic cell death.

No abstract

Porously assembled 2D nanosheets of alkali metal manganese oxides were synthesized via the flocculation of exfoliated MnO2 nanosheets with alkali metal cations. According to X-ray diffraction and electron microscopic analyses, the MnO2 nanosheets were porously restacked with alkali metal cations, resulting in the mesoporous assembly of lamellar crystallites with surface expansion (∼50−70 m2 g− 1). Mn K-edge X-ray absorption spectroscopy clearly demonstrated that manganese ions in the reassembled materials were stabilized in octahedral symmetry with the mixed oxidation state of Mn3+/Mn4+. The present reassembled manganates showed large capacitances of ∼140−160 F g−1 and excellent cyclability of ∼93−99% up to the 1000th cycle. The electrochemical cycling did not induce notable frustration in the crystal structure of manganate nanosheets, underscoring the high structural stability of the reassembled manganates. This study provided strong evidence for the effectiveness of the exfoliation−reassembling method in enhancing the capacitance performance of layered metal oxides.

Severe acute respiratory syndrome coronavirus (SARS-CoV) is the etiological agent of a newly emerged disease SARS. The SARS-CoV nucleocapsid (N) protein is one of the most abundant structural proteins and serves as a diagnostic marker for accurate and sensitive detection of the virus. Using a SELEX (systematic evolution of ligand by exponential enrichment) procedure and recombinant N protein, we selected a high-affinity RNA aptamer capable of binding to N protein with a dissociation constant of 1.65 nM. Electrophoretic mobility shift assays and RNA competition experiments showed that the selected aptamer recognized selectively the C-terminal region of N protein with high specificity. Using a chemiluminescence immunosorbent assay and a nanoarray aptamer chip with the selected aptamer as an antigen-capturing agent, we could sensitively detect N protein at a concentration as low as 2 pg/ml. These aptamer-antibody hybrid immunoassays may be useful for rapid, sensitive detection of SARS-CoV N protein.

In this study, we describe a novel approach to human cancer therapy that is based upon trans-splicing ribozyme-mediated replacement of cancer-specific RNAs with new transcripts that exert therapeutic activities. We have developed a specific ribozyme that can reprogram human telomerase reverse transcriptase (hTERT) RNA to induce transgene activity selectively in cancer cells that express the RNA. The ribozyme-mediated triggering of the transgene expression was accomplished via a high-fidelity trans-splicing reaction with the targeted residue in the hTERT-expressing cells. The ribozyme also induced cytotoxic activity in various hTERT-expressing cancer cells, hence selectively retarding the growth of those cells. Efficient and specific cell regression was also detected with ganciclovir (GCV) treatment only in hTERT-positive cancer cells, which were established to express stably the specific ribozyme that contains the herpes simplex virus thymidine kinase (HSV-tk) gene. Tissue-specific expression of the ribozyme could further augment the target specificity of the ribozyme. Importantly, we observed efficient regression of tumors with GCV treatment in mice that had been inoculated subcutaneously with hTERT-positive cancer cells that stably expressed the specific ribozyme that contains HSV-tk. These results suggest that the hTERT RNA-targeting trans-splicing ribozyme could be a powerful agent for tumor-targeted specific gene therapy.

BackgroundAccumulation of beta-amyloid and neuroinflammation trigger Alzheimer’s disease. We previously found that lipopolysaccharide (LPS) caused neuroinflammation with concomitant accumulation of beta-amyloid peptides leading to memory loss. A variety of anti-inflammatory compounds inhibiting nuclear factor kappaB (NF-κB) activation have showed efficacy to hinder neuroinflammation and amyloidogenesis. We also found that bee venom (BV) inhibits NF-κB.MethodsA mouse model of LPS-induced memory loss used administration of BV (0.8 and 1.6 μg/kg/day, i.p.) to ICR mice for 7 days before injection of LPS (2.5 mg/kg/day, i.p.). Memory loss was assessed using a Morris water maze test and passive avoidance test. For in vitro study, we treated BV (0.5, 1, and 2 μg/mL) to astrocytes and microglial BV-2 cells with LPS (1 μg/mL).ResultsWe found that BV inhibited LPS-induced memory loss determined by behavioral tests as well as cell death. BV also inhibited LPS-induced increases in the level of beta-amyloid (Aβ), β-and γ-secretases activities, NF-κB and its DNA-binding activity and expression of APP, and BACE1 and neuroinflammation proteins (COX-2, iNOS, GFAP and IBA-1) in the brain and cultured cells. In addition, pull-down assay and molecular modeling showed that BV binds to NF-κB.ConclusionsBV attenuates LPS-induced amyloidogenesis, neuroinflammation, and therefore memory loss via inhibiting NF-κB signaling pathway. Thus, BV could be useful for treatment of Alzheimer’s disease.

New phases of Zn-Co-layered double hydroxides (Zn-Co-LDHs) were synthesized for the first time via a co-precipitation reaction using hydrogen peroxide as an oxidant. According to powder X-ray diffraction and field emission-scanning electron microscopy, both nitrate-and sulfate-forms of the Zn-Co-LDHs crystallized with the brucite-type layer structure having interlayer nitrate and sulfate anions, respectively, and commonly showed plate-like morphology with a crystal size of several hundred nanometers. dc magnetic susceptibility measurements revealed that the Zn-Co-LDHs displayed ferromagnetic/antiferromagnetic transitions below 15 K and the magnetic moment calculated from the paramagnetic region (30-300 K) indicated the co-existence of weak field Co 2+ and strong field Co 3+ ions. The mixed oxidation state of Co 2+ /Co 3+ was confirmed by the results of iodometry and X-ray absorption near-edge structure spectroscopy. The heat-treatment for the Zn-Co-LDHs at elevated temperatures produced mixed metal oxide nanocomposites composed of spinel ZnCo 2 O 4 and wurzite ZnO phases. The colloidal suspension of exfoliated Zn-Co-LDH nanosheets could be synthesized by dispersion of the pristine LDH materials in formamide, which was confirmed by the Tyndall phenomenon, high resolution-transmission electron microscopy/selected area electron diffraction, and UV-vis spectroscopy. The Zn-Co-LDH film fabricated with the restacked nanosheets exhibited pseudocapacitive behavior with a large specific capacitance and a good capacitance retention. The present findings underscore that the newly synthesized mixed valence Zn-Co-LDH phases showed promising functionality as a supercapacitor electrode material and also showed interesting magnetic coupling behavior.